D.E. Shaw & Co
OBIO icon

D.E. Shaw & Co’s Orchestra BioMed OBIO Stock Holding History

D.E. Shaw & Co’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-938,388
Closed -$9.35M – 5446
2022
Q2 		$9.35M Buy
938,388
+51,487
+6% +$512K 0.02% 1451
2022
Q1 		$8.79M Buy
886,901
+108,119
+14% +$1.07M 0.01% 1719
2021
Q4 		$7.79M Buy
778,782
+526,264
+208% +$5.19M 0.01% 1917
2021
Q3 		$2.5M Buy
252,518
+222,717
+747% +$2.2M ﹤0.01% 2829
2021
Q2 		$304K Buy
+29,801
New +$308K ﹤0.01% 4272

Other funds holding OBIO

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $4.65B AUM 56.47% 1-Year Est. Return